The Mary Tyler Moore Vision Initiative is proud to announce that Leo Kim has received the Research to Prevent Blindness | Mary Tyler Moore Vision Initiative 2024 Physician-Scientist Award, which focuses on cutting-edge retinal research to expand relevant knowledge and to develop methods to preserve and restore visual function in people with DRD. Dr. Kim is the Monte J. Wallace Ophthalmology Chair in Retina at Massachusetts Eye and Ear and is currently working on using mRNA as a therapy in the eye. He states, “This therapy is the first to deliver mRNA-based treatments inside the eye. We were pleasantly surprised that we could use this approach inside the eye without causing excessive inflammation. We hope that these early findings can usher in new treatment options for PVR and other eye diseases.” To learn more about Dr. Kim and the study, please visit the link below: https://www.ophthalmologytimes.com/view/mrna-therapy-shows-promise-for-treating-proliferative-vitreoretinopathy
